OnBioVC NEWS:

- OnBioVC Announces Beta Launch of Service
- OnBioVC INDEX(TM) Updated thru DEC 2009
- OnBioVC 2009 Year-in-Review, now available
- OnBioVC 1Q10 Trend Analysis, coming soon

SEARCH THE OnBioVC DATABASE:

23

Jun

2009

Xanodyne Pharmaceuticals, Inc.: Series D $38M

Posted in I - Series D, Q - 2Q09, R - SOUTH EAST, X - Menorrhagia, X - Pain, XX - KY

Xanodyne Pharmaceuticals (Newport, KY) an clinical-stage specialty pharmaceutical company focused on pain and menorrhagia, closed a $38M Series D financing. Participants include MPM Capital, AIG Investments, Aisling Capital, Blue Chip Venture Company, Essex Woodlands Health Ventures, HealthCare Ventures and Union Springs Pharmaceuticals.

to top of page...

Venture Capital Investors
5AM Ventures Abingworth Management ARCH Venture Partners Aurora Funds Bay City Capital Bessemer Venture Partners Burrill & Co. Chicago Growth Partners CHL Medical Partners Clarus Ventures Credit Agricole Private Equity Delphi Ventures DeNovo Ventures Domain Associates Edmond de Rothschild Investment Partners Essex Woodlands Health Ventures Forbion Capital Partners Foundation Medical Partners HBM Bioventures Imperial Innovations Interwest Partners Kleiner Perkins Life Sciences Partners MedVenture Associates MPM Capital MVM Life Science Partners New Enterprise Associates Novartis Venture Fund Novo Ventures Oxford Bioscience Partners Oxford Finance Polaris Venture Partners Quaker BioVentures Sanderling Ventures Scale Venture Partners SV Life Sciences Texas Emerging Technology Fund Third Rock Ventures Thomas McNerney Partners TPG Growth Venrock Ventech Versant Ventures Wellcome Trust

OnBioVC Friends

IguanaBio
EyeOnFDA
Patent Baristas
Pharma's Cutting Edge
MedTechIQ
The Antibody Blog
BioJobBlog

OnBioVC Partners